ATOPIC DERMATITIS / ECZEMA
Clinical trials for ATOPIC DERMATITIS / ECZEMA explained in plain language.
Never miss a new study
Get alerted when new ATOPIC DERMATITIS / ECZEMA trials appear
Sign up with your email to follow new studies for ATOPIC DERMATITIS / ECZEMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Light vs lotion: Head-to-Head eczema battle
Disease control OngoingThis study tests whether adding UVB light therapy to standard skin creams works better than using creams alone for adults with moderate-to-severe eczema. 316 participants were randomly assigned to receive either the light therapy plus creams or just creams for at least 3 months. …
Matched conditions: ATOPIC DERMATITIS / ECZEMA
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Baby skin cream trial aims to stop food allergies before they start
Prevention OngoingThis study is testing whether a special skin care routine for babies with early eczema can prevent them from developing food allergies. Researchers are comparing two approaches: a proactive treatment using a barrier cream and a mild steroid versus standard reactive care. The goal…
Matched conditions: ATOPIC DERMATITIS / ECZEMA
Phase: PHASE2 • Sponsor: Kari Nadeau, MD, PhD • Aim: Prevention
Last updated Mar 27, 2026 12:40 UTC
-
Could your breast milk hold the key to your Baby's allergies?
Knowledge-focused OngoingThis study aims to understand if tiny molecules called microRNAs in a mother's breast milk affect a baby's chance of developing allergies like eczema, wheezing, or food allergies in their first year. Researchers will follow 221 breastfeeding mother-baby pairs, collecting breast m…
Matched conditions: ATOPIC DERMATITIS / ECZEMA
Sponsor: Milton S. Hershey Medical Center • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:41 UTC
-
A randomized, double-blind, placebo-controlled, multicenter, phase 2 study to evaluate the efficacy and safety of HY209 gel in patients with mild to moderate atopic Dermatitis(AD)
OngoingThis is a randomized, double-blind, placebo-controlled, multi-center, phase 2 study in patients with mild to moderate Atopic Dermatitis(AD), which consists of 2 parts.
Matched conditions: ATOPIC DERMATITIS / ECZEMA
Phase: PHASE2 • Sponsor: Shaperon
Last updated Mar 02, 2026 15:22 UTC